HLA-G gene repression is reversed by demethylation

被引:136
作者
Moreau, P
Mouillot, G
Rousseau, P
Marcou, C
Dausset, J
Carosella, ED
机构
[1] Hop St Louis, Inst Univ Hematol, CEA,Serv Rech Hamatoimmunol, Direct Sci Vivant,Dept Rech Med, F-75010 Paris, France
[2] Fdn Jean Dausset, Ctr Etud Polymorphisme Humain, F-75010 Paris, France
关键词
D O I
10.1073/pnas.0337539100
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
The HLA-G molecule plays an important role in immune tolerance, protecting the fetus from maternal immune attack, and probably contributes to graft tolerance and tumor escape from the host immune system. HLA-G expression is tightly regulated and involves mechanisms acting in part at the transcriptional level. Nevertheless, almost all regulatory sequences that govern constitutive and inducible HLA class I gene transcription are disrupted in the HLA-G gene promoter, suggesting an unusual regulatory process. In further investigating the molecular mechanisms of HLA-G gene activation, we evaluated the influence of epigenetic mechanisms on seven HLA-G-negative cell lines that exhibit various phenotypes. Exposure of cells to histone deacetylase inhibitors, or to the demethylating agent 5-aza-2'-deoxycytidine, revealed that HLA-G gene transcription is inhibited by DNA methylation. Reversal of methylation-mediated repression may directly induce HLA-G cell-surface expression, supporting the idea that HLA-G might be activated by such a mechanism during malignancy, inflammation, and allogenic reactions.
引用
收藏
页码:1191 / 1196
页数:6
相关论文
共 71 条
[1]   HLA-G class I gene expression in normal and malignant hematopoietic cells [J].
Amiot, L ;
Onno, M ;
Drénou, B ;
Monvoisin, C ;
Fauchet, R .
HUMAN IMMUNOLOGY, 1998, 59 (08) :524-528
[2]   HLA-G and NK receptor are expressed in psoriatic skin - A possible pathway for regulating infiltrating T cells? [J].
Aractingi, S ;
Briand, N ;
Le Danff, C ;
Viguier, M ;
Bachelez, H ;
Michel, L ;
Dubertret, L ;
Carosella, ED .
AMERICAN JOURNAL OF PATHOLOGY, 2001, 159 (01) :71-77
[3]   Leukemia inhibitory factor (LIF) stimulates the human HLA-G promoter in JEG3 choriocarcinoma cells [J].
Bamberger, AM ;
Jenatschke, S ;
Schulte, HM ;
Löning, T ;
Bamberger, CM .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2000, 85 (10) :3932-3936
[4]   DNA methylation patterns and epigenetic memory [J].
Bird, A .
GENES & DEVELOPMENT, 2002, 16 (01) :6-21
[5]   Endothelial cells in chorionic fetal vessels of first trimester placenta express HLA-G [J].
Blaschitz, A ;
Lenfant, F ;
Mallet, V ;
Hartmann, M ;
Bensussan, A ;
Geraghty, DE ;
Le Bouteiller, P ;
Dohr, G .
EUROPEAN JOURNAL OF IMMUNOLOGY, 1997, 27 (12) :3380-3388
[6]   HLA-G: a shield against inflammatory aggression [J].
Carosella, ED ;
Moreau, P ;
Aractingi, S ;
Rouas-Freiss, N .
TRENDS IN IMMUNOLOGY, 2001, 22 (10) :553-555
[7]  
Colonna M, 1998, J IMMUNOL, V160, P3096
[8]   A common inhibitory receptor for major histocompatibility complex class I molecules on human lymphoid and myelomonocytic cells [J].
Colonna, M ;
Navarro, F ;
Bellon, T ;
Llano, M ;
Garcia, P ;
Samaridis, J ;
Angman, L ;
Cella, M ;
LopezBotet, M .
JOURNAL OF EXPERIMENTAL MEDICINE, 1997, 186 (11) :1809-1818
[9]   Posttranscriptional regulation of human leukocyte antigen G during human extravillous cytotrophoblast differentiation [J].
Copeman, J ;
Han, RNN ;
Caniggia, I ;
McMaster, M ;
Fisher, SJ ;
Cross, JC .
BIOLOGY OF REPRODUCTION, 2000, 62 (06) :1543-1550
[10]   A novel immunoglobulin superfamily receptor for cellular and viral MHC class I molecules [J].
Cosman, D ;
Fanger, N ;
Borges, L ;
Kubin, M ;
Chin, W ;
Peterson, L ;
Hsu, ML .
IMMUNITY, 1997, 7 (02) :273-282